PCK1 and hepatocellular carcinoma: PCK1 deficiency could also promote HCC cell proliferation by inactivating AMPK, inhibiting p27Kip1 expression, and induce CDK/Rb/E2F activation, which supports cell cycle transition from the G1 to S phase upon low glucose stimulation (Tuo et al., 2019).